Introduction: Family planning is one of the pillars of the Safe Motherhood Initiative which is aimed at reducing unwanted pregnancy and maternal death. Objective: To evaluate the uptake, efficacy, and safety profile of 68 mg etonogestrel subdermal implant in Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Ebonyi State. Materials and Methods: A 5-year retrospective descriptive analysis was carried out on 68 mg etonogestrel subdermal implant uptake among family planning attendees in AEFUTHA. The medical records of the clients that had 68 mg etonogestrel subdermal implant insertion were studied. Socio-demographic characteristics, side effects, discontinuation, and reasons for discontinuation were extracted and analyzed. Analysis was done with SPSS version 20. Data obtained were represented using frequency tables and pie chart. Results: During the study period, 2538 women accepted various methods of contraception, 14.3% (364) of the women used Implanon. The mean age of 68 mg etonogestrel subdermal implant users was 30.7 ± 13.4 years with a range of 20 - 44. Multiparous clients constituted 54.5%. The majority (55.2%) had secondary education as their highest level of education. Less than 20% of the acceptors had side effects, the commonest 24 (42.9%) being prolonged menstrual flow and followed by irregular menstrual flow 18 (32.1%). Discontinuation rate was 17.9%; desire to conceive. 40 (61.5%) was the commonest reason for discontinuation. Only one (0.3%) acceptor reported serious itching at the site of insertion. None of the women reported pregnancy during the period of use (Pearl Index = 0). Conclusion: The acceptance rate of 68 mg etonogestrel subdermal implant among the women is low, however, it is found be effective with good continuation rate in the center. Efforts should be made to increase its uptake so as to prevent unwanted pregnancy and associated sequelae.
References
[1]
Jacobstein, R. and Stanley, H. (2013) Contraceptive Implants: Providing Better Choice to Meet Growing Family Planning Demand. Global Health, 1, 11-17. https://doi.org/10.9745/GHSP-D-12-00003
[2]
WHO, UNICEF, UNFPA and The World Bank Estimates (2012) Trends in Maternal Mortality: 1990 to 2010. WHO, UNICEF, UNFPA and the World Bank Estimates.
[3]
Abasiattai, A.M, Utuk, N.M. and Inyang-Etoh, E.C. (2014) Subdermal Contraceptive Implants: Profile of Acceptors in a Tertiary Hospital in Southern Nigeria. International Journal of Gynecology, Obstetrics and Neonatal Care, 1, 9-13. https://doi.org/10.15379/2408-9761.2014.01.01.3
[4]
Aisien, A.O. and Enosolease, M.E. (2010) Safety, Efficacy and Acceptability of Implanon a Single Rod Implantable Contraceptive (Etonogestrel) in University of Benin Teaching Hospital. Nigerian Journal of Clinical Practice, 13, 331-335.
[5]
Balogun, O.R., Olaomo, N., Adeniran, A.S. and Fawole, A.A. (2014) Implanon Sub-Dermal Implant: An Emerging Method of Contraception in Ilorin, Nigeria. Journal of Medical and Biomedical Sciences, 3, 1-5. https://doi.org/10.4314/jmbs.v3i1.1
[6]
Ezegwui, H.U., Ikeako, L.C., Ishiekwene, C.I. and Oguanua, T.C. (2010) The Discontinuation Rate and Reasons for Discontinuation of Implanon at the Family Planning Clinic of University of Nigeria Teaching Hospital Enugu, Nigeria. Nigerian Journal of Medicine, 20, 448-450.
[7]
Madugu, N.H., Abdul, M.A, Bawa, U. and Kolawole, B. (2015) Uptake of Hormonal Implants Contraceptive in Zaria, Northern Nigeria. Open Journal of Obstetrics and Gynecology, 5, 268-273. https://doi.org/10.4236/ojog.2015.55039
[8]
Mutihir, J.T. and Nyango, D.D. (2010) One-Year Experience with Implanon Sub-Dermal Implants in Jos, Nigeria. Nigerian Journal of Clinical Practice, 13, 28-31.
[9]
Ojule, J.D., Oranu, E.O. and Enyindah, C.E. (2012) Experience with Implanon in Southern Nigeria. The Journal of Medical Sciences, 3, 710-714.
[10]
Mastor, A., Khaing, L.S. and Omar, S.Z. (2011) Users Perspectives on Implanon in Malaysia, a Multicultural Asian Country. Open Access Journal of Contraception, 2, 79-84. https://doi.org/10.2147/OAJC.S9674
[11]
Monga, A. and Dobbs, S. (2011) Fertility Control, Contraception and Abortion. In: Monga, A. and Dobbs, S., Eds., Gynaecology by Ten Teachers, Book Power, London, Article 216. https://doi.org/10.1201/b13218
[12]
Asnake, M., Henry, E.G., Tilahun, Y., Oliveras, E. (2013) Addressing Unmet Need for Long‐Acting Family Planning in Ethiopia: Uptake of Single‐Rod Progestogen Contraceptive Implants (Implanon) and Characteristics of Users. International Journal of Gynecology & Obstetrics, 123, e29-e32. https://doi.org/10.1016/j.ijgo.2013.07.003
[13]
Shehu, C.E. and Burodo, A.T. (2013) Contraceptive Choices among Women Attending the Fertility Research Unit of Usmanu Danfodiyo University Teaching Hospital, Sokoto. Sahel Medical Journal, 16, 93-96. https://doi.org/10.4103/1118-8561.121906
[14]
Okafor, I.I. (2016) Uptake of Long-Acting Reversible Contraceptive Methods in Enugu State University Teaching Hospital Enugu, South-East, Nigeria. Divers Equal Health Care, 13, 216-220. https://doi.org/10.21767/2049-5471.100055
[15]
Birhane, K., Hagos, S. and Fantahun, M. (2015) Early Discontinuation of Implanon and its Associated Factors among Women Who Ever Used Implanon in Ofla District, Tigray, Northern Ethiopia. International Journal of Pharmaceutical Sciences and Research, 6, 544-551.
[16]
Duvan, C.İ., Gözdemir, E., Kaygusuz, İ., Kamalak, Z., and Turhan, N.Ö. (2010) Etonogestrel Contraceptive Implant (Implanon): Analysis of Patient Compliance and Adverse Effects in the Breastfeeding Period. Journal of the Turkish-German Gynecological Association, 11, 141-144.
[17]
Egede, J.O., Onoh, R.C., Umeora, O.U., Iyoke, C.A., Dimejesi, I.B. and Lawani, L.O. (2015) Contraceptive Prevalence and Preference in a Cohort of South-East Nigerian Women. Patient Prefer Adherence, 9, 707-714. https://doi.org/10.2147/PPA.S72952
[18]
Benfield, N. and Darney, P.D. (2011) Contraceptive Implants. In: Shoupe, D., Ed., Contraception, Wiley-Blackwell, 57-66. https://doi.org/10.1002/9781444342642.ch5
